HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J Talc Setback: Missouri Court Decision Keeps Out-Of-State Plaintiff Door Open

This article was originally published in The Rose Sheet

Executive Summary

The numerous out-of-state plaintiffs waiting to take on J&J in Missouri over alleged talc harm may be able to litigate their cases after all, despite a recent US Supreme Court decision against plaintiff venue shopping. A Missouri circuit court judge has found grounds for jurisdiction in J&J's use of a Missouri-based manufacturing and packaging firm.

You may also be interested in...



2017 In Review: Plaintiffs Find New Angles For Attacking Cosmetics' Authenticity

Rose Sheet's coverage of consumer litigation targeting personal-care companies for deceptive claims, among other alleged violations, yielded some of its most-read stories in 2017, based on online analytics. Trends are likely to carry over and, in some cases, pick up steam in 2018.

J&J Wins Reversal Of $72M Talc Verdict, Signaling Whole New Ballgame

What has seemed an endless queue of plaintiffs waiting to litigate claims against J&J in Missouri for alleged talc harm may begin thinning out following a June mistrial and now the reversal of an earlier $72m verdict against the company, both due to jurisdictional issues dictated by a recent Supreme Court ruling.

J&J May Have Just Received Lifeline Out Of St. Louis Talc Tort Morass

A judge in the Missouri state court where J&J has suffered a series of hefty losses declared a mistrial June 19 in the latest talc-cancer case to be heard by jurors. The decision came two days after a US Supreme Court decision that also could trigger reversals of costly J&J verdicts currently under appeal.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121358

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel